Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Providencia stuartii

Identifiers: BioSample: SAMN04014867; Sample name: FDA-CDC-AR_0026; SRA: SRS1256858

Organism: Providencia stuartii
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Morganellaceae; Providencia

Attributes

BioProject: PRJNA292901 Enterobacteriaceae Carbapenem Breakpoint genome sequencing and assembly
Retrieve all samples from this project

Submission: Centers for Disease Control and Prevention, Brian Yoo; 2015-08-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	susceptible	<=	1	mg/L	MIC	CLSI
amoxicillin-clavulanic acid	resistant	>	32/16	mg/L	MIC	CLSI
ampicillin	resistant	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	susceptible	==	8/4	mg/L	MIC	CLSI
aztreonam	susceptible	<=	2	mg/L	MIC	CLSI
cefazolin	resistant	>	8	mg/L	MIC	CLSI
cefepime	susceptible	<=	0.5	mg/L	MIC	CLSI
cefotaxime	susceptible	<=	1	mg/L	MIC	CLSI
cefoxitin	susceptible	<=	2	mg/L	MIC	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	CLSI
ceftriaxone	susceptible	<=	1	mg/L	MIC	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	CLSI
colistin	not defined	>	4	mg/L	MIC	CLSI
doripenem	susceptible	==	0.25	mg/L	MIC	CLSI
ertapenem	susceptible	<=	0.12	mg/L	MIC	CLSI
gentamicin	susceptible	==	0.5	mg/L	MIC	CLSI
imipenem	susceptible	<=	0.5	mg/L	MIC	CLSI
levofloxacin	susceptible	==	1	mg/L	MIC	CLSI
meropenem	susceptible	<=	0.12	mg/L	MIC	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	CLSI
polymyxin B	not defined	>	4	mg/L	MIC	CLSI
tetracycline	resistant	>	32	mg/L	MIC	CLSI
tigecycline	susceptible	==	2	mg/L	MIC	CLSI
tobramycin	susceptible	<=	0.25	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	0.25/4.75	mg/L	MIC	CLSI